md phd

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Audio23:38Notes
   +Listen later
2. 2▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Video23:38Notes
   +Watch later
3. 3▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Oncology & Haematology Video32:12Notes
   +Watch later
4. 4▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Audio19:20Notes
   +Listen later
5. 5▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Audio32:12Notes
   +Listen later
6. 6▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Video19:20Notes
   +Watch later
7. 7▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Video32:12Notes
   +Watch later
8. 8▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Audio19:20Notes
   +Listen later
9. 9▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Video19:20Notes
   +Watch later
10. 10▶Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment OutcomesPeerVoice Oncology & Haematology Video1:20:49Notes
    +Watch later
11. 11▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Oncology & Haematology Video26:33Notes
    +Watch later
12. 12▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Audio26:33Notes
    +Listen later
13. 13▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Audio17:39Notes
    +Listen later
14. 14▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Audio16:39Notes
    +Listen later
15. 15▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Video26:33Notes
    +Watch later
16. 16▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Video17:39Notes
    +Watch later
17. 17▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Video16:39Notes
    +Watch later
18. 18▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Audio26:33Notes
    +Listen later
19. 19▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Audio16:39Notes
    +Listen later
20. 20▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Video16:39Notes
    +Watch later
21. 21▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Video26:33Notes
    +Watch later
22. 22▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Audio1:17:14Notes
    +Listen later
23. 23▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Video1:17:14Notes
    +Watch later
24. 24▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Audio1:17:14Notes
    +Listen later
25. 25▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Video1:17:14Notes
    +Watch later
26. 26▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Audio1:17:14Notes
    +Listen later
27. 27▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Video1:17:14Notes
    +Watch later
28. 28▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Audio25:41Notes
    +Listen later
29. 29▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Video25:41Notes
    +Watch later
30. 30▶Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME InitiativePeerVoice Oncology & Haematology Video21:06Notes
    +Watch later
31. 31▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Audio25:41Notes
    +Listen later
32. 32▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Video25:41Notes
    +Watch later
33. 33▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Immunology & Infectious Disease Audio20:43Notes
    +Listen later
34. 34▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Oncology & Haematology Video18:45Notes
    +Watch later
35. 35▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Oncology & Haematology Video19:41Notes
    +Watch later
36. 36▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Audio20:43Notes
    +Listen later
37. 37▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Audio18:45Notes
    +Listen later
38. 38▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Audio19:41Notes
    +Listen later
39. 39▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Video20:43Notes
    +Watch later
40. 40▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Video18:45Notes
    +Watch later
41. 41▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Video19:41Notes
    +Watch later
42. 42▶Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice SettingsPeerVoice Oncology & Haematology Video28:23Notes
    +Watch later
43. 43▶Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck CancerPeerVoice Oncology & Haematology Video54:23Notes
    +Watch later
44. 44▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Audio20:17Notes
    +Listen later
45. 45▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Audio29:54Notes
    +Listen later
46. 46▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Video20:17Notes
    +Watch later
47. 47▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Video29:54Notes
    +Watch later
48. 48▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Audio35:42Notes
    +Listen later
49. 49▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Video35:42Notes
    +Watch later
50. 50▶Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology MasterclassPeerVoice Oncology & Haematology Video29:59Notes
    +Watch later